SFS
MITO

Sowell Financial Services’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Sowell Financial Services’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,939
Closed -$5K – 3051
2021
Q1 		$5K Hold
2,939
– – ﹤0.01% 2635
2020
Q4 		$4K Buy
+2,939
New +$4.12K ﹤0.01% 2369

Other funds holding MITO

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SBL
Sargent Bickham Lagudis Boulder, Colorado $1.22B AUM 14.94% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Sowell Financial Services's MITO Position: Q2 2021 in Review

Sowell Financial Services sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q2 2021, closing a stake of 2,939 shares — an estimated $5K sold.

Sowell Financial Services first reported a position in MITO in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 12 funds tracked by Wall St. Rank hold MITO as of Q2 2021.

  • Sowell Financial Services reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,939 Stealth BioTherapeutics Corp. ADS shares in Q2 2021, an estimated $5K.
  • Sowell Financial Services first reported a position in Stealth BioTherapeutics Corp. ADS in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Stealth BioTherapeutics Corp. ADS position peaked at $5K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.